BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8952460)

  • 1. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Prentice GA; Merrill AR
    Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa exotoxin A: effects of mutating tyrosine-470 and tyrosine-481 to phenylalanine.
    Lukac M; Collier RJ
    Biochemistry; 1988 Oct; 27(20):7629-32. PubMed ID: 2849995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescence investigation of the active site of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Merrill AR
    J Biol Chem; 1999 May; 274(22):15646-54. PubMed ID: 10336461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A.
    Armstrong S; Merrill AR
    Biochemistry; 2004 Jan; 43(1):183-94. PubMed ID: 14705944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY; Galloway DR
    J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interaction using tryptophan analogues: novel spectroscopic probes for toxin-elongation factor-2 interactions.
    Mohammadi F; Prentice GA; Merrill AR
    Biochemistry; 2001 Aug; 40(34):10273-83. PubMed ID: 11513605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature and character of the transition state for the ADP-ribosyltransferase reaction.
    Jørgensen R; Wang Y; Visschedyk D; Merrill AR
    EMBO Rep; 2008 Aug; 9(8):802-9. PubMed ID: 18583986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enzyme-linked immunosorbent assay for the association of the catalytic domain of diphthamide-specific ribosyltransferases to eukaryotic elongation factor-2.
    Prentice GA; Merrill AR
    Anal Biochem; 1999 Aug; 272(2):216-23. PubMed ID: 10415091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa.
    Bourdenet S; Vacheron MJ; Guinand M; Michel G; Arminjon F
    Eur J Biochem; 1990 Sep; 192(2):379-85. PubMed ID: 2170123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the catalytic mechanism of Pseudomonas aeruginosa exotoxin A. Studies of toxin interaction with eukaryotic elongation factor-2.
    Armstrong S; Yates SP; Merrill AR
    J Biol Chem; 2002 Nov; 277(48):46669-75. PubMed ID: 12270928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
    Yates SP; Merrill AR
    Biochem J; 2004 May; 379(Pt 3):563-72. PubMed ID: 14733615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
    Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
    Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.
    Yates SP; Taylor PL; Jørgensen R; Ferraris D; Zhang J; Andersen GR; Merrill AR
    Biochem J; 2005 Feb; 385(Pt 3):667-75. PubMed ID: 15458385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analysis of exotoxin A proteins with mutations at histidine 426.
    Wick MJ; Cook JM; Iglewski BH
    Infect Immun; 1992 Mar; 60(3):1128-39. PubMed ID: 1541528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active-site mutations of diphtheria toxin. Tryptophan 50 is a major determinant of NAD affinity.
    Wilson BA; Blanke SR; Reich KA; Collier RJ
    J Biol Chem; 1994 Sep; 269(37):23296-301. PubMed ID: 8083236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the enzymatic active site of Pseudomonas aeruginosa exotoxin A.
    Brandhuber BJ; Allured VS; Falbel TG; McKay DB
    Proteins; 1988; 3(3):146-54. PubMed ID: 3151219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity.
    Wedekind JE; Trame CB; Dorywalska M; Koehl P; Raschke TM; McKee M; FitzGerald D; Collier RJ; McKay DB
    J Mol Biol; 2001 Dec; 314(4):823-37. PubMed ID: 11734000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a fluorometric assay for characterization of the catalytic competency of a domain III fragment of Pseudomonas aeruginosa exotoxin A.
    Armstrong S; Merrill AR
    Anal Biochem; 2001 May; 292(1):26-33. PubMed ID: 11319814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa exotoxin A: alterations of biological and biochemical properties resulting from mutation of glutamic acid 553 to aspartic acid.
    Douglas CM; Collier RJ
    Biochemistry; 1990 May; 29(21):5043-9. PubMed ID: 1974145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.